ScholarGate
Assistent

Hypothalamic Releasing Hormones

Hypothalamic releasing hormones are small peptides made by specialised hypothalamic neurons that control the anterior pituitary. Secreted into the hypophyseal portal blood, they either stimulate or inhibit the release of specific pituitary hormones, making the hypothalamus the neural gateway to the endocrine system.

Leia teema tööriistaga PaperMindPeagiFind papers & topics
Tools & resources
Laadi slaidid alla
Learn & explore
VideoPeagi

Definition

Hypothalamic releasing hormones are neuropeptides synthesised by hypothalamic neurons and delivered through the hypophyseal portal system to the anterior pituitary, where each selectively stimulates or inhibits the secretion of one or more pituitary hormones.

Scope

The topic covers the identity, sources, and actions of the principal hypothalamic releasing and inhibiting hormones (such as TRH, GnRH, CRH, GHRH, somatostatin, and dopamine), how they reach the anterior pituitary through the portal circulation, and the pulsatile manner in which several of them are released. It is a physiology topic, not clinical guidance.

Core questions

  • Which hypothalamic hormone controls each anterior pituitary hormone?
  • How does the hypophyseal portal system deliver these peptides to the pituitary?
  • Why are several releasing hormones secreted in pulses rather than continuously?
  • How do stimulatory and inhibitory hypothalamic signals jointly set pituitary output?

Key concepts

  • Thyrotropin-releasing hormone (TRH)
  • Gonadotropin-releasing hormone (GnRH)
  • Corticotropin-releasing hormone (CRH)
  • Growth hormone-releasing hormone (GHRH)
  • Somatostatin (inhibitory)
  • Dopamine as prolactin-inhibiting factor
  • Hypophyseal portal circulation
  • Pulsatile secretion

Mechanisms

Peptidergic neurons in defined hypothalamic nuclei release their hormones at the median eminence into the primary capillary plexus of the hypophyseal portal system. The portal veins carry these peptides directly to the anterior pituitary, exposing target cells to far higher concentrations than would be possible through the general circulation. Each releasing hormone binds receptors on a specific pituitary cell type, triggering second-messenger cascades that promote (or, for inhibitory factors such as somatostatin and dopamine, suppress) hormone synthesis and exocytosis. Many of these signals are delivered in pulses, and for the gonadotropin axis the frequency of GnRH pulses, set by a hypothalamic pulse generator, is itself an information-carrying variable.

Clinical relevance

Because each releasing hormone maps to a particular pituitary output, this map underlies how the levels of the endocrine cascade are reasoned about when an axis is disturbed, and synthetic analogues of these peptides are used as physiological probes. The topic explains normal control mechanisms and is not a basis for individual diagnosis or treatment.

Evidence & guidelines

The existence and chemical identity of hypothalamic releasing hormones were established by the isolation and sequencing work of Schally and Guillemin and colleagues in the 1960s and 1970s, including the characterisation of TRH, GnRH, and somatostatin, work recognised with the 1977 Nobel Prize in Physiology or Medicine. Later reviews refined the understanding of pulsatile control, particularly for the gonadotropin axis.

History

After Geoffrey Harris proposed that the hypothalamus controls the anterior pituitary humorally through the portal vessels, two competing laboratories spent years processing enormous quantities of hypothalamic tissue to isolate the responsible substances. TRH was characterised first, followed by GnRH and the inhibitory peptide somatostatin, confirming Harris's hypothesis and founding modern molecular neuroendocrinology.

Key figures

  • Andrew V. Schally
  • Roger Guillemin
  • Wylie Vale
  • Allan E. Herbison

Related topics

Seminal works

  • schally-1973
  • brazeau-1973
  • guillemin-1978

Frequently asked questions

Are all hypothalamic factors stimulatory?
No. Some are inhibitory: somatostatin restrains growth hormone (and TSH) release, and dopamine tonically inhibits prolactin secretion. Net pituitary output reflects the balance of stimulatory and inhibitory signals.
How do releasing hormones reach the pituitary so selectively?
They are released at the median eminence into the hypophyseal portal vessels, a short, direct vascular route that delivers them to the anterior pituitary in high concentration before they are diluted in the systemic circulation.

Methods for this concept

Related concepts